celecoxib has been researched along with Auricular Fibrillation in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three prospective patient cohorts were created: Healthy patients (n = 35), inflammatory arthritis patients with no celecoxib use (n = 22), and inflammatory arthritis patients treated with celecoxib (n = 20)." | 7.80 | Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients. ( Abdollah, H; Averns, HL; Baranchuk, A; Michael, KA; Pizzuto, K; Redfearn, DP; Simpson, C, 2014) |
| "The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod." | 5.38 | A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012) |
| "Three prospective patient cohorts were created: Healthy patients (n = 35), inflammatory arthritis patients with no celecoxib use (n = 22), and inflammatory arthritis patients treated with celecoxib (n = 20)." | 3.80 | Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients. ( Abdollah, H; Averns, HL; Baranchuk, A; Michael, KA; Pizzuto, K; Redfearn, DP; Simpson, C, 2014) |
| " Our patient had arthritis of the hips and chronic atrial fibrillation and was on warfarin therapy for stroke prevention; less than a week after starting celecoxib therapy, gastrointestinal bleeding and hypoprothrombinemia occurred." | 3.70 | Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia. ( Davis, JV; Linder, JD; Mönkemüller, KE; Wilcox, CM, 2000) |
| "The psoriatic arthritis was treated with celecoxib and multiple sclerosis with fingolimod." | 1.38 | A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? ( Cocco, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pizzuto, K | 1 |
| Averns, HL | 1 |
| Baranchuk, A | 1 |
| Abdollah, H | 1 |
| Michael, KA | 1 |
| Simpson, C | 1 |
| Redfearn, DP | 1 |
| Bäck, M | 1 |
| Yin, L | 1 |
| Ingelsson, E | 1 |
| Cocco, G | 1 |
| Linder, JD | 1 |
| Mönkemüller, KE | 1 |
| Davis, JV | 1 |
| Wilcox, CM | 1 |
4 other studies available for celecoxib and Auricular Fibrillation
| Article | Year |
|---|---|
Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients.
Topics: Analysis of Variance; Arthritis; Atrial Fibrillation; Celecoxib; Cohort Studies; Cyclooxygenase 2 In | 2014 |
Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Epidemiologic | 2012 |
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?
Topics: Arthritis, Psoriatic; Atrial Fibrillation; Autoimmune Diseases; Celecoxib; Cyclooxygenase Inhibitors | 2012 |
Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthritis; Atrial Fibrillation; Bicar | 2000 |